ATYR
Atyr Pharma Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$0.85
-0.02 ▼ -2.02%
🌙 3월 13일 7:56 PM ET (한국 3/14 08:56)
$0.86
+0.01 ▲ +1.42%
| Index | RUT | P/E | - | EPS (ttm) | -0.8 | Insider Own | 2.5% | Shs Outstand | 0.10B | Perf Week | 3.16% |
| Market Cap | 0.08B | Forward P/E | - | EPS next Y | 29.69% | Insider Trans | 68.16% | Shs Float | 0.10B | Perf Month | -8.29% |
| Enterprise Value | 0.02B | PEG | - | EPS next Q | -0.13 | Inst Own | 56.18% | Short Float | 19.67% | Perf Quarter | 4.17% |
| Income | -0.07B | P/S | 438.63 | EPS this Y | 26.67% | Inst Trans | -6.96% | Short Ratio | 9.44 | Perf Half Y | -83.84% |
| Sales | 0.00B | P/B | 1.23 | EPS next 5Y | 37.27% | ROA | -77.12% | Short Interest | 18.80M | Perf YTD | 8.54% |
| Book/sh | 0.69 | P/C | 1.06 | EPS past 3/5Y | 20.65% 14.76% | ROE | -107.81% | 52W High | -88.34% ($7.29) | Perf Year | -78.7% |
| Cash/sh | 0.8 | P/FCF | - | Sales past 3/5Y | -73.65% -55.14% | ROIC | -94.97% | 52W Low | 32.81% ($0.64) | Perf 3Y | -56.41% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 8.34% | Gross Margin | -717.37% | Volatility(W/M) | 7.58% 8.72% | Perf 5Y | -82.72% |
| Dividend TTM | - | EV/Sales | 86.79 | Sales Y/Y TTM | -19.15% | Oper. Margin | -40856.32% | ATR (14) | 0.08 | Perf 10Y | -98.81% |
| Dividend Ex-Date | - | Quick Ratio | 5.3 | EPS Q/Q | 21.23% | Profit Margin | -39009.47% | RSI (14) | 44.01 | Recom | 2.33 |
| Dividend Gr. 3/5Y | - | Current Ratio | 5.3 | Sales Q/Q | - | SMA20 | -10.74% ($0.95) | Beta | 0.59 | Target Price | $4.36 |
| Payout | - | Debt/Eq | 0.18 | Earnings | 3000000 | SMA50 | -0.19% ($0.85) | Rel Volume | 0.4 | Prev Close | $0.87 |
| Employees | 58 | LT Debt/Eq | 0.16 | EPS/Sales Surpr. | 23.83% -100% | SMA200 | -66.14% ($2.51) | Avg Volume(3M) | 1.99M | Price | $0.85 |
| IPO | 2015/5/7 | Option/Short | Yes/Yes | Trades | 2736 | Volume | 791,090 | Change | -2.02% |
뉴스 로딩 중...